Franck Zal
Vorstandsvorsitzender bei Hemarina SA
Profil
Franck Zal is the founder of Hemarina SA, a company founded in 2007.
He currently holds the position of Chairman, CEO & Chief Scientific Officer at Hemarina SA. Dr. Zal is also currently working as the Director at France Biotech Association and as a Member-Supervisory Board at Inserm-Transfert SA. Dr. Zal obtained his doctorate degree from Université Paris 1 Panthéon-Sorbonne in 1996.
Aktive Positionen von Franck Zal
Unternehmen | Position | Beginn |
---|---|---|
Hemarina SA
Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Vorstandsvorsitzender | 21.12.2009 |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Direktor/Vorstandsmitglied | 06.08.2010 |
Inserm-Transfert SA
Inserm-Transfert SA Miscellaneous Commercial ServicesCommercial Services Inserm-Transfert SA engages in the managements of economic and societal value creation and the transfer of knowledge. It operates in the human health innovation sector. The company was founded in 2000 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | - |
Ausbildung von Franck Zal
Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Hemarina SA
Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Health Technology |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Commercial Services |
Inserm-Transfert SA
Inserm-Transfert SA Miscellaneous Commercial ServicesCommercial Services Inserm-Transfert SA engages in the managements of economic and societal value creation and the transfer of knowledge. It operates in the human health innovation sector. The company was founded in 2000 and is headquartered in Paris, France. | Commercial Services |